跳至主要内容
临床试验/DRKS00005742
DRKS00005742已完成未知

Post-market clinical follow-up investigation of the marketed Extended Range of Vision IOL (Intraocular lens) - EROV-108-COMP

Abbott Medical Optics Inc.0 个研究点目标入组 147 人开始时间: 2014年3月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
147

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
22 Years 至 one(—)
性别
All

入选标准

  • · Minimum 22 years of age
  • · Planned natural lens replacement with posterior chamber IOL implantation
  • · Visual potential of 20/25 or better in the operative eye following natural lens
  • replacement with an IOL
  • · Normal corneal topography
  • · Clear intraocular media other than cataract in each eye
  • · Availability, willingness, sufficient cognitive awareness to comply with examination
  • · Ability to sign informed consent

排除标准

  • · Requiring an intraocular lens power outside the available range of +16.0 D to
  • · Patients with recurrent severe anterior or posterior segment inflammation or uveitis
  • of unknown etiology, or any disease producing an inflammatory reaction in the eye
  • · Patients in whom the intraocular lens may affect the ability to observe, diagnose or
  • treat posterior segment diseases
  • · Expected surgical difficulties at the time of cataract extraction, which may increase
  • the potential for complications (e.g., persistent bleeding, significant iris damage,
  • uncontrolled positive pressure or significant vitreous prolapse or loss)
  • · A compromised eye due to previous trauma or developmental defects in which
  • appropriate support of the IOL is not possible
  • · Circumstances that would result in damage to the endothelium during implantation
  • · Suspected microbial infection
  • · Patients in whom neither the posterior capsule nor the zonules are intact enough
  • to provide support for the IOL
  • · Congenital bilateral cataracts
  • · Previous history of, or a predisposition to, retinal detachment
  • · Patients with only one good eye with potentially good vision
  • · Medically uncontrollable glaucoma
  • · Corneal endothelial dystrophy
  • · Proliferative diabetic retinopathy
  • · Patient is pregnant, plans to become pregnant, is lactating or has another
  • condition associated with the fluctuation of hormones that could lead to refractive
  • · Concurrent participation or participation within 30 days prior to preoperative visit in
  • any other clinical trial

研究者

相似试验